Tango Therapeutics Inc (TNGX) — Cash Flow Reinvestment Rate
Tango Therapeutics Inc (TNGX) has a Cash Flow Reinvestment Rate of 0.63x as of September 2020, reinvesting $69.75 Million (capex $132.00K plus investments $-69.62 Million) from operating cash flow of $111.26 Million. See how much free cash does Tango Therapeutics Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tango Therapeutics Inc Cash Flow Reinvestment Rate (2020–2020)
Historical reinvestment intensity for Tango Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see Tango Therapeutics Inc (TNGX) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Tango Therapeutics Inc (2020–2020)
Year-by-year capital reinvestment analysis for Tango Therapeutics Inc. See how financially flexible is Tango Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 2.08x | $145.43 Million | $70.07 Million | $1.11 Million | — |